Development of a three-dimensional CysLT1 (LTD4) antagonist model with an incorporated amino acid residue from the receptor

Journal of Medicinal Chemistry
M E ZwaagstraM Q Zhang

Abstract

This paper describes the molecular modeling of leukotriene CysLT1 (or LTD4) receptor antagonists. Several different structural classes of CysLT1 antagonists were superimposed onto the new and highly rigid CysLT1 antagonist 8-carboxy-3'-[2-(2-quinolinyl)ethenyl]flavone (1, VUF 5017) to generate a common pharmacophoric arrangement. On the basis of known structure-activity relationships of CysLT1 antagonists, the quinoline nitrogen (or a bioisosteric equivalent thereof) and an acidic function were taken as the matching points. In order to optimize the fitting of acidic moieties of all antagonists, an arginine residue from the receptor was proposed as the interaction site for the acidic moieties. Incorporation of this amino acid residue into the model revealed additional interactions between the guanidine group and the nitrogen atoms of quinoline-containing CysLT1 antagonists. In some cases, the arginine may even interact with pi-clouds of phenyl residues of CysLT1 antagonists. The alignment of Montelukast (MK-476) suggests the presence of an additional pocket in the binding site for CysLT1 antagonists. The derived model should be useful for a better understanding of the molecular recognition of the leukotriene CysLT1 receptor.

References

Dec 1, 1991·Journal of Computer-aided Molecular Design·R B Hermann, D K Herron
Oct 1, 1987·The American Review of Respiratory Disease·J M Drazen, K F Austen
Jan 1, 1985·Prostaglandins·C D PerchonockJ F DeVan
Dec 28, 1983·Biochemical and Biophysical Research Communications·J G GleasonM A Wasserman
May 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J M DrazenE J Corey
May 1, 1995·International Archives of Allergy and Immunology·J M Drazen, E Israel
Feb 1, 1995·International Journal of Immunopharmacology·R R HarrisD W Brooks
Feb 15, 1995·European Journal of Pharmacology·P G JonesE C Hulme
Oct 1, 1995·Journal of Lipid Mediators and Cell Signalling·K M Metters
Sep 15, 1988·Physical Review A: General Physics·A D Becke

❮ Previous
Next ❯

Citations

May 29, 2002·Bioorganic & Medicinal Chemistry Letters·Lídia M LimaEliezer J Barreiro
Jan 7, 2017·The Journal of Organic Chemistry·Ya-Ping HanYong-Min Liang
Jan 24, 2017·Organic Letters·Zhenhao ZhangYangjie Wu
Jun 10, 2004·Bioorganic & Medicinal Chemistry·Paolo BenedettiGiorgio Ottaviani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.